Mark Colabella, Dell
Mark Colabella is Vice President, Enterprise Tax Planning, Compliance and Defense at Dell. Responsible for Dell Enterprise and legacy EMC business, a $25 billion revenue leader in computer storage, software and information life cycle management, Mark leads a team of 20 global employees. His specialties are tax planning, U.S. corporate tax law and mergers and acquisitions.
Eileen Comstock, Biogen
Eileen Comstock is a Senior Tax Director at Biogen, Inc. Eileen leads the International Tax Team at Biogen focusing on US international and foreign tax planning, transfer pricing and business development support. Biogen is a global developer, marketer and manufacturer of therapies for people living with serious neurological, autoimmune and rare diseases. Biogen had $12 billion in revenue in 2017 and foreign affiliates in over 30 countries.
Lewis Greenwald, DLA Piper
Lewis Greenwald is a Partner with DLA Piper. Lew focuses on international tax planning and structuring for multinational companies, including tax-efficient acquisitions, dispositions, reorganizations and repatriations; migrating intellectual property to tax-favored jurisdictions; transfer pricing; foreign currency gains/losses; dual consolidated losses; and FTC/OFL planning.
Chris Kelley, Ernst & Young
Chris Kelley is a Partner in EY’s Boston office in the International Tax Practice.
Amelia O'Beirne, A&L Goodbody
Amelia O'Beirne is a Tax Partner with A&L Goodbody. Amelia has extensive experience of advising on the tax aspects of corporate restructurings, complex cross border financing transactions, US multinational tax planning, mergers and acquisitions. She advises a broad base of clients in various business sectors, including insurance, manufacturing, pharmaceuticals and investment funds.
Mark Organisak, Vertex Pharmaceuticals
Mark Organisak is Vice President of Tax and Insurance at Vertex Pharmaceuticals, a $2.5 billion revenue global biotechnology company. Mark leads the tax function and is responsible for developing US and international tax strategies and transfer pricing policies. Before working at Covidien and ARIAD Pharmaceuticals, he spent the early part of his career as an international tax partner at PwC.
Norm Richter, Babson College and BU School of Law
Norm Richter teaches courses in Strategic Business and Tax Planning, Tax Policy and Income Taxation at Babson College and Boston University’s School of Law. Norm was the chief tax executive for Baxalta Inc. a biopharmaceutical multinational company focused on hematology, immunology and oncology, until Baxalta was acquired in June 2016 by Shire for $32 billion.
Rom Watson, Ropes & Gray
Rom Watson is a Partner with Ropes & Gray. Rom concentrates his practice on international tax issues, and serves as the co-head of the firm’s International practice group. He has extensive experience in the international tax area. He focuses on the tax issues raised by cross-border fund formation, financial products, transfer pricing, and multinational transactions.